Frost & Sullivan

Healthcare


Pharmaceuticals and Clinical Diagnostics - Technical Insights Industry Subscription

The Pharmaceuticals and Clinical Diagnostics Vertical Industry subscription provides analysis of and timely information on all recent developments.

Title Published
Genetic Technology Alert. Study of Adult Genome’s Correlated Biological Role in Dental Caries; Visual Cycle Modulation Therapy To Treat Dry-AMD; Building Synthetic Modular Human Monoclonal Antibody Libraries on Miniaturized Devices 26 Apr 2013
Genetic Technology Alert. HPV Test Based on Urine Analysis; Gene Biomarkers Linked To Scleroderma Personalized Therapy Discovered; Targeted ADAM 17 and EFGR To Treat Dermal Fibrosis 19 Apr 2013
Nanotech Alert. Nanosponge Effectively Removes Toxins from Bloodstream; Faster and Lighter Transistors Made Possible with Redesigned Material 19 Apr 2013
2013 Top Medical Device and Imaging Technologies (Technical Insights)
Breakthrough Medical Technologies that open new vistas for healthcare delivery 		15 Apr 2013
Nanotech Alert. Using Nanocrystals for Manufacturing Efficient Batteries; Nanocellulose Material from Algae; Nanotechnology Transforms Molecular Beams Into Functional Nanodevices 12 Apr 2013
Drug Discovery Technology Alert. Enhanced Genotoxicity Platform for Drug Discovery and Environment Biomonitoring; Avoiding Multi-Drug Resistance through Antibacterial Drug Discovery Platform 12 Apr 2013
Genetic Technology Alert. Tissue Engineering of Adipogenic Hydrogel and Investigation of its Adipogenesis Properties; Genetic Links for Childhood Obesity Identified; CRTH2 Antagonist for Treatment of Allergic Asthma 12 Apr 2013
Trends in Nanofluidics and BioNEMS (Technical Insights)
A 9-dimensional Study on the Future of Miniaturized Systems 		08 Apr 2013
Nanotech Alert. Material for Manufacturing Chemical Vapor Sensors; Swarming Nanobots Can Revolutionize Healthcare and Defence Sectors; Liquid Lifting through Nanowires Can Benefit Inkjet Printing 05 Apr 2013
Genetic Technology Alert. Immunomodulation Strategy by Immunostimulatory Sequences To Target Toll-Like Receptor-9; Genetic Risk Factors for Ovarian Cancer Identified 05 Apr 2013

About this service

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..